Journal of Evidence-Based Integrative Medicine,
Journal Year:
2024,
Volume and Issue:
29
Published: Jan. 1, 2024
Hypertrophic
scarring
is
an
aberrant
wound-healing
response
to
reestablish
dermal
integrity
after
injury
and
can
cause
significant
abnormalities
in
physical,
aesthetic,
functional,
psychological
symptoms,
impacting
the
patient's
quality
of
life.
There
currently
no
gold
standard
for
preventing
treating
hypertrophic
scars.
Therefore,
many
researchers
have
attempted
search
antihypertrophic
scar
agents
with
greater
efficacy
fewer
side
effects.
Natural
therapeutics
are
becoming
attractive
as
potential
alternative
anti-scarring
because
their
high
efficacy,
safety,
biocompatibility,
low
cost,
easy
accessibility.
This
review
demonstrates
various
kinds
natural
product-based
therapeutics,
including
onion,
vitamin
E,
Gotu
kola,
green
tea,
resveratrol,
emodin,
curcumin,
others,
terms
mechanisms
action,
evidence
advantages,
disadvantages
when
used
agents.
We
reviewed
literature
based
on
data
from
vitro,
vivo,
clinical
trials.
A
total
23
trials
were
identified
this
review;
most
ranked
having
uncertain
results
(level
2b;
n
=
16).
Although
these
products
showed
beneficial
effects
both
vitro
vivo
studies
agents,
there
was
limited
support
due
studies,
individual
flaws
small
sample
sizes,
poor
randomization,
blinding,
short
follow-up
durations.
More
robust
well-designed
large-scale
prolonged
durations
required
clarify
benefits
risks
Polymers,
Journal Year:
2025,
Volume and Issue:
17(1), P. 108 - 108
Published: Jan. 2, 2025
Disruption
of
the
molecular
pathways
during
physiological
wound
healing
can
lead
to
raised
scar
formation,
characterized
by
rigid,
thick
tissue
with
associated
symptoms
pain
and
pruritus.
A
key
mechanical
factor
in
development
is
excessive
tension
at
site.
Recently,
microneedles
(MNs)
have
emerged
as
promising
tools
for
management
they
engage
provide
them
off-loading
from
both
internal
external
sources.
This
review
explores
mechanisms
which
physical
intervention
drug-free
MNs
alleviates
on
fibroblasts
within
tissue,
thereby
promoting
remodeling
reducing
severity.
Additionally,
role
an
efficient
cargo
delivery
system
controlled
sustained
release
a
wide
range
therapeutic
agents
into
highlighted.
By
penetrating
facilitate
localized
drug
administration
modulate
inflammation
fibroblastic
cell
growth.
Finally,
remaining
challenges
future
perspective
field
been
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 4, 2025
Spalt-like
transcription
factor
4
(SALL4)
plays
a
vital
role
in
the
progression
of
many
human
diseases.
However,
and
mechanism
SALL4
regulates
keloid
formation
remain
unclear.
The
mRNA
levels
ubiquitin-specific
peptidase
37
(USP37)
tissues
fibroblasts
were
determined
by
quantitative
real-time
PCR.
Western
blot
was
performed
to
measure
protein
SALL4,
USP4/10/37,
collagen-related
markers,
PI3K/AKT-related
markers.
growth,
invasion
migration
using
CCK8
assay,
EdU
flow
cytometry,
transwell
assay
wound
healing
assay.
Cell
glycolysis
assessed
detecting
glucose
consumption
lactate
production.
interaction
between
USP37
confirmed
co-immunoprecipitation
had
increased
expression
fibroblasts.
Silencing
inhibited
invasion,
migration,
extracellular
matrix
(ECM)
accumulate
fibroblast,
while
its
overexpression
opposite
effects.
In
terms
mechanism,
stabilized
through
deubiquitinating.
Functional
experiments
suggested
that
reversed
inhibitory
effect
knockdown
on
fibroblast
functions.
Moreover,
USP37/SALL4
axis
could
increase
activity
PI3K/AKT
pathway,
PI3K
pathway
inhibitor
LY294002
abolished
SALL4-mediated
promoting
USP37-activated
might
enhance
ECM
accumulation
via
activating
pathway.
Aesthetic Plastic Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Hypertrophic
scars
are
a
common
fibrotic
skin
disorder
with
high
recurrence
rate.
While
various
treatment
options
exist,
their
efficacy
remains
uncertain.
Manual
fractional
technology
CO2
laser
technology,
novel
approach,
has
shown
promise;
however,
its
effectiveness
as
standalone
ablative
is
limited.
This
retrospective
study
aims
to
evaluate
the
clinical
outcomes
of
combining
triamcinolone
acetonide
and
5-fluorouracil
transdermal
delivery
for
hypertrophic
scars.
retrospectively
evaluated
MFT
combined
in
treating
A
cohort
42
patients
48
underwent
combination
therapy
thrice.
Scar
evaluations
were
conducted
using
patient
observer
scar
assessment
scale
(POSAS)
before
one
month
after
each
session.
Adverse
complication
reactions
monitored,
followed
6
months
post-treatment.
satisfaction
assessed.
The
total
POSAS
score
significantly
decreased
from
pre-treatment
[48.00
(43.00,
53.75)
VS
21.29±7.167;
p<0.001].
In
subgroup
analysis,
varied
by
type,
quantity
genetic
factors
influencing
remission
time.
rate
during
6-month
follow-up
was
6.24%,
83.34%.
No
severe
adverse
reported.
findings
indicate
that
laser-assisted
drug
demonstrates
significant
efficacy,
low
rate,
an
absence
serious
method
shows
promise
modality
journal
requires
authors
assign
level
evidence
article.
For
full
description
these
Evidence-Based
Medicine
ratings,
please
refer
Table
Contents
or
online
Instructions
Authors
www.springer.com/00266
.
Pakistan Journal of Health Sciences,
Journal Year:
2025,
Volume and Issue:
unknown, P. 270 - 275
Published: March 31, 2025
Keloid
treatment
remains
a
challenging
task
due
to
the
high
recurrence
rates
and
limited
effectiveness
of
monotherapies.
Objective:
To
determine
efficacy
combining
intralesional
Triamcinolone
Acetonide
(TA)
with
cryotherapy.
Methods:
A
quasi-experimental
study
was
conducted
at
Dermatology
Department,
Nishtar
Hospital,
Multan,
over
6
months
from
30th
June
2024,
December
31,
2024.
Eighty
patients
were
enrolled
using
non-probability
consecutive
sampling.
Baseline
characteristics,
including
keloid
dimensions,
pain,
itching
scores,
documented.
Patients
received
cryotherapy
followed
by
TA
(40
mg/mL)
injections
for
up
six
sessions.
Treatment
outcomes
assessed
two
weeks
post-treatment
through
reduction
in
height,
length,
Visual
Analog
Scale
(VAS)
scores.
Results:
The
mean
height
length
reduced
significantly
4.66
±
1.37
mm
1.69
1.18
6.64
2.23
cm
2.68
1.79
cm,
respectively
(p
<
0.001)
post-treatment.
VAS
pain
scores
decreased
2.86
1.96,
3.53
1.39
0.001).
Efficacy,
defined
as
≥50%
achieved
75%
participants.
Common
adverse
effects
included
blistering
(18.8%)
erythema
(15%).
Conclusions:
combination
triamcinolone
acetonide
demonstrated
effective
significant
improvement
Although
varied
across
demographic
lesion-specific
variables,
safe
viable
option
management,
manageable
promising
outcomes.
Lasers in Medical Science,
Journal Year:
2025,
Volume and Issue:
40(1)
Published: Jan. 23, 2025
Abstract
Hypertrophic
scars
(HTSs)
are
the
result
of
an
abnormal
healing
process
resulting
from
burns
and
other
severe
traumas.
The
symptoms
that
condition
include
skin
irritation,
discomfort,
itching.
This
study
aimed
to
assess
efficacy
fractional
carbon
dioxide
(CO
2
)
laser
therapy
alone
or
with
triamcinolone
5-fluorouracil
(FU)
in
treatment
early
post-burn
hypertrophic
develop
during
first
6
months
after
injury.
A
prospective,
randomized,
single-blind
comparative
was
conducted
on
30
patients
aged
16–65
(HTS)
burns.
Patients
had
no
prior
for
their
scars.
We
randomly
assigned
participants
one
three
groups:
Group
received
CO
alone,
B
topical
5-fluorouracil,
C
acetonide.
All
groups
showed
significant
improvements
(
p
<
0.05)
overall
scar
severity
height.
(fractional
+
triamcinolone)
demonstrated
pliability,
height,
pigmentation
0.05).
In
contrast,
5-FU)
reductions
vascularity,
height
following
While
all
reported
minor
changes
pain
itching,
there
were
differences
these
between
C.
HTSs
this
trial
revealed
surface
area
thickness
improvement
pliability
pigmentation;
however,
not
statistically
difference
effect
acetonide
(TAC),
suggesting
neither
drug
offers
better
over
other.
Level
I,
singleblinded
randomized
control
study.
The FASEB Journal,
Journal Year:
2025,
Volume and Issue:
39(7)
Published: March 28, 2025
Abstract
Galectin‐1,
a
constituent
of
the
mammalian
β‐galactoside‐binding
lectin
family,
plays
pivotal
regulatory
role
in
fibrotic
cascades.
Dysregulated
fibrogenic
cellular
activity
has
been
implicated
as
critical
driver
hypertrophic
scar
(HS)
pathogenesis.
Nevertheless,
precise
mechanistic
contributions
and
molecular
pathways
through
which
Galectin‐1
modulates
HS
development
remain
incompletely
characterized.
qRT‐PCR
western
blot
techniques
were
employed
to
explore
expression
tissues
cells.
The
knockdown
cell
line
was
established
by
utilizing
lentivirus
approach,
influences
on
biological
functions
examined.
mechanism
underlying
regulation
investigated
via
RNA‐seq
analysis,
immunofluorescence,
Western
blot.
Subsequently,
combined
with
RT‐PCR
used
investigate
Galectin‐1's
alternative
splicing.
exhibits
significant
overexpression
pathological
activated
fibroblasts.
Genetic
silencing
effectively
attenuates
fibroblast
(HSF)
proliferation,
migration,
invasive
capacities
while
downregulating
markers.
Transcriptomic
functional
analyses
reveal
that
orchestrates
concurrent
PANoptosis
ferroptosis
regulates
ROS
pathway
modulating
ES
splicing
NASP,
this
process
depends
HNRNPL.
Overall,
HSF
cells
thereby
regulating
cascade.
Our
findings
indicate
is
regulator
formation,
offering
novel
therapeutic
target
direction
for
treatment.
Archives of The Medicine and Case Reports,
Journal Year:
2024,
Volume and Issue:
5(3), P. 721 - 727
Published: May 24, 2024
Keloids
are
abnormal
cutaneous
wound
healing
responses
extending
beyond
the
borders
of
initial
wound,
usually
appearing
pink-purplish
to
hyperpigmented
nodules
or
plaques
with
a
hard
consistency,
irregular
shape,
uneven
border,
and
smooth
shiny
surface.
Most
often
occur
on
chest,
shoulder,
upper
arms,
earlobes,
cheeks.
This
case
report
aims
compare
keloid
treated
intralesional
triamcinolone
acetonide
(TAC)
alone
acetonide-5-fluorouracil
(TAC
+
5-FU)
combination
injection.
A
21-year-old
Minahasa
male
complains
growing
pruritic
scars
in
back
area
right
left
arms
since
five
years
ago.
Physical
examination
revealed
multiple
plaques,
irregularly
shaped,
smooth,
surfaces
defined
varying
sizes.
clinical
diagnosis
was
made.
Treatment
initiated
weekly
TAC
arm
vs.
5-FU
injection
arm.
The
evaluation
made
based
modified
Vancouver
scar
scale.
One
most
commonly
used
therapeutic
options
for
is
TAC.
However,
may
be
opted
due
its
mechanism
through
corticosteroid
action
conjunction
antimetabolite
activity
5-FU.
yield
more
effective
faster
outcome
fewer
side
effects.
Intralesional
option
minimal